Adverum Biotechnologies
ADVM
ADVM
59 hedge funds and large institutions have $97.9M invested in Adverum Biotechnologies in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $104M → $97.9M (-$6.45M)
25% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 20
Holders
59
Holding in Top 10
2
Calls
$420K
Puts
–
Top Buyers
| 1 | +$4.03M | |
| 2 | +$715K | |
| 3 | +$356K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$191K |
| 5 |
Renaissance Technologies
New York
|
+$170K |
Top Sellers
| 1 | -$1.86M | |
| 2 | -$1.6M | |
| 3 | -$1.23M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$509K |
| 5 |
AI
Acuitas Investments
Seattle,
Washington
|
-$483K |